OPTM Healthcare Unveils Flagship Clinic In South Extension New Delhi

The new clinic is designed on 3,500 square feet across, with advanced diagnostic labs and cutting-edge technology all for completely comprehensive, integrated services designed to aid diagnosis, pain management, and transformative care. The clinic is developed on the concept of the "Bio-Musculo Index," a diagnostic innovation that has evolved after years of therapeutic research. Backed by Varco Leg Care, India's leading consumer health-tech brand dedicated to leg care, this is the world's first AI-enabled tool. It scores 10 biomarkers to score muscular health, assess muscle age, and formulate individualised treatment plans based on proprietary AI algorithms.

Also Read: Fortis Escorts, Okhla Achieves India’s First Successful Treatment Of Bilateral Wilms Tumour In Children

OPTM's muscle-focused treatment protocol incorporates its patented phyto-topical formulations with revolutionary motion-sensing technology, allowing measurable progress. This nontoxic, side-effect-free therapy works at the cellular level to reverse degeneration, eliminate recurring pain, and even reduce the need for joint surgeries in many cases.

Dr. Raghav Sehgal of Yale University's Ph.D. and Dr. Michael Lim from Singapore, longevity experts, inaugurated the clinic. They focus on muscular health to extend the human health spans. Suresh Jain, Managing Director, Sanicon Ventures, was impressed by the innovative approaches applied by OPTM in regenerative medicine and AI-driven diagnostics.

OPTM Healthcare Founder and Chief Scientific Officer Dr. Apoorva Ganguli discussed evidence-based, plant-derived therapy to reverse muscle ageing through cellular repair and restoration. The clinic also has FDA-approved cryotherapy and lymphatic compression equipment.

OPTM has unveiled plans to launch 10 new clinics in nine months as it grows its team of physiotherapists, health coaches, Ayurvedic doctors, and orthopaedic surgeons. The event concluded with a guided tour of the facility and an outstanding demonstration of OPTM's AI-powered biomarker testing, setting a new standard in pain management and muscular healthcare.